Kiniksa Pharmaceuticals International, plc (KNSA) › EPS (Diluted)Kiniksa Pharmaceuticals International, plc (KNSA) — EPS (Diluted)Annual figures by period end, from SEC filings.2019-12-31: $-2.992020-12-31: $-2.612021-12-31: $-2.302022-12-31: $2.602023-12-31: $0.202024-12-31: $-0.602025-12-31: $0.75$0.752019-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$0.75—2026-02-24From 2025-01-012024-12-31$-0.60-400.0%2026-02-24From 2024-01-012023-12-31$0.20-92.3%2026-02-24From 2023-01-012022-12-31$2.60—2025-02-25From 2022-01-012021-12-31$-2.30—2024-02-28From 2021-01-012020-12-31$-2.61—2023-03-02From 2020-01-012019-12-31$-2.99—2022-02-24From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)